Loading…
Arbor Biotechnologies is developing novel gene editing treatments for people living with genetic diseases. The company uses a diverse toolbox of next-generation gene editors to create therapeutic applications across a broad range of conditions.
AI named Arbor Biotechnologies from December 2025 to March 2026.